Equity Capital And Reserves Cambio Fecha
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Aceragen USD 22.55M 16.39M 2023-03
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
BioCryst Pharmaceuticals USD -410986000 22.27M 2023-09
Biogen USD 14.8B 315.6M 2023-12
BioMarin Pharmaceutical USD 4.95B 54.65M 2023-12
Bluebird Bio USD 222.54M 66.48M 2023-09
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Exelixis USD 2.35B 180.32M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
Incyte USD 5.19B 258.39M 2023-12
Ionis Pharmaceuticals USD 386.69M 71.23M 2023-12
Lumos Pharma USD 35.49M 8.17M 2023-09
Merck USD 41.25B 2.55B 2023-09
Moderna USD 13.85B 399M 2023-12
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
Pfizer USD 96.93B 2.08B 2023-09
PTC Therapeutics USD -818555000 147.74M 2023-12
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Ultragenyx Pharmaceutical USD 275.41M 243.7M 2023-12
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09



Incyte Capital Y Las Reservas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.